Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,273
Total Claims
$1.4M
Drug Cost
630
Beneficiaries
$2,279
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-87%
Opioid rate vs peers
0.3% vs 2.2% avg
+62%
Cost per patient vs peers
$2,279 vs $1,411 avg
+6%
Brand preference vs peers
11.3% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
40
Opioid Claims
$310
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,471 claims · $1.1M
Generic: 11,542 claims · $370K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 259 | $266K |
| Sitagliptin Phosphate | 200 | $204K |
| Icosapent Ethyl | 202 | $134K |
| Dapagliflozin Propanediol | 58 | $90K |
| Linagliptin | 74 | $77K |
| Semaglutide | 43 | $62K |
| Icosapent Ethyl | 71 | $39K |
| Atorvastatin Calcium | 1,691 | $38K |
| Raloxifene Hcl | 358 | $37K |
| Acarbose | 260 | $20K |
| Lipase/Protease/Amylase | 27 | $18K |
| Enalapril Maleate | 498 | $18K |
| Apixaban | 17 | $16K |
| Mirabegron | 17 | $16K |
| Amlodipine Besylate | 913 | $16K |
Prescribing Profile
Patient Profile
75
Avg Age
56%
Female
1.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data